Medical Toxicology Expert Witnesses in Pennsylvania

This highly qualified Professor of Pharmaceutical Sciences received a bachelors in Pharmacy and a PharmD in Clinical Pharmacy. He is a member of numerous highly regarded professional organizations including the American Association of Pharmaceutical Scientists and the American College of Clinical Pharmacology. He is an innovator with 10 patents registered in his name. He is widely published in Pharmaceutical literature with over 350 articles. In addition to his academic role he currently serves as CEO of three Pharmaceutical companies.

This expert began his career as a medical consultant to the emergency room drug treatment and referral program. He’s been practicing for over 40 years and focuses on internal medicine, consulting in clinical pharmacology, and quality assurance medicine. He is currently involved in many aspects of pharmacology, and holds many positions on boards and committees related to drug abuse, prevention, and treatment. He has been a special government employee consultant for the US Department of Health and Human Services, Public Health Service Food and Drug Administration, and Center for Drug Evaluation. He has numerous patents, trademarks, fellowships, grants, and publication and presentations.

This highly qualified expert has been conducting academic studies in toxicology for 30+ years. He completed his postdoctoral and fellowship training at Rochester University. He is a fellow at the American Association for the Advancement of the Sciences and a member of numerous professional associations, including the Academy of Toxicological Sciences, where he serves in the board of directors. He is also the past president of the International Neurotoxicology Association. He has authored approximately 300 peer-reviewed manuscripts and chapters in the area of neurotoxicology and serves on the editorial board of several journals. He is the former director of clinical pharmacology and toxicology at Vanderbilt and the former director of the NIEHS Molecular Toxicology Center. Currently, he is a professor and chair of molecular pharmacology at a major university in New York.

This highly qualified expert has years of experience in using animal models to study diabetes. He received his PhD degree from Ohio State University and completed his fellowship training in physiology and biophysics at the University of Illinois. He has published 98+ peer-reviewed journal articles and serves as a reviewer for 26+ renowned medical journals. He has been listed in "Who's Who in America" for science and engineering and lectures nationwide. Currently, he is a professor of pharmaceutical science and research and the director of pharmacology and toxicology at a major university. He is also the director of the Center for Diagnostic Nanosystems and the associate director of the Cell Differentiation and Development Center at the same institution. Additionally, he is the biological sciences laboratory supervisor at another major university.

This expert is board certified psychiatrist and addiction specialist, and also is certified by the American Board of Disability Analysts. He is an expert in handling capital, personal injury, loss mitigation, malpractice and negligence cases that involve the use of abused substances (especially, opiates, alcohol, hallucinogens, and stimulants), prescribed pharmacological agents, and in the general field of psychiatric and brain disease. This expert also is a leading neuroscientist and neuropsychopharmacologist. He can provide expert testimony on the effects of different brain states and function, in both health and disease, and their potential association with with legal culpability and liability. He currently serves as the Chairman of the Department of Psychiatry at a leading university in the USA, and has over 12 years experience as Chairman in Psychiatry Departments in the USA. His research focus is in the neuropsychopharmacology of addiction, addiction and pain, pain treatment, impact of genetics on human behavior, the basic, molecular, and the brain imaging sciences related to the functioning of the brain in health, disease and addiction. In recognition of his academic, scholarly and professional achievement, he is a Fellow of the Collegium Internationale Neuro-psychopharmacologicum and a Distinguished Fellow of the American Psychiatric Association. He is the recipient of numerous professional and scientific awards, including the Jack Mendelson Award at the NIH, which is awarded to individuals who have made distinguished contributions to our understanding of the science of addiction. He has an h-index of 46, and 11829 citations of his published work.

This expert is Board of Governors Professor in the Institute for Health, Health Care Policy and Aging Research and the School of Social Work for a leading NJ University. At the Institute, he directs the Center for Health Services Research on Pharmacotherapy, Chronic Disease Management, and Outcomes, whose programs include the AHRQ-funded Center for Education and Research on Mental Health Therapeutics. He also is Chair of the Institute's Division on Aging and Associate Institute Director for Health Services Research. His work, which has resulted in more than 250 publications, includes many widely cited books and research articles on old-age policy and services for the elderly; on the use and outcomes of psychotropic medications and other mental health treatments; on HIV/AIDS care; and on numerous other health care and social policy topics. His work on gerontological policy and inequality has been particularly influential nationally, as the cumulative advantage model of aging which he originally proposed in the 1980s and has developed in a line of subsequent work has contributed to understanding of late-life inequalities and the way in which initial advantages such as educational attainment; social structures; health and economic events over the lifecourse; and public policies interact to shape late-life outcomes. He has also been an important contributor to research on long-term care and mental health among the elderly. His work on mental health services has contributed importantly to understanding problems of healthcare access, quality and disparities in large usual care populations, particularly those served by Medicare and Medicaid. Much of his recent work has focused on prescription drug use in society where he has pioneered important studies on treatment use, safety, and effectiveness, including current work on comparative effectiveness of treatments funded by the FDA and the Agency for Healthcare Research and Quality. In 2009, his contributions to scholarship on health services and outcomes were recognized by his appointment as Board of Governors Professor of Health Services Research at a leading NJ University with the university's Board of Governors citing his "major theoretical, methodological, and research contributions in the fields of aging, HIV care, and behavioral health; his highly influential and social policy scholarship; the impressive rigor of his cross-disciplinary research contributions that have shaped thinking, both in the U.S. and abroad, on issues confronting some of the most vulnerable groups in our society" and for his "numerous and enormously influential books, journal articles, reports, and other publications . and his outstanding contributions to improving decision-making in public policy as evidenced by his frequent invitations to testify before and advise Congress and other policymakers."

This extremely qualified neurologist with over 20 years of experience, hundreds of publications and abstracts, author of multiple books is a leading pioneer in his field. He completed his medical education in Tunisia and then completed his residency in neurology at Temple university, where he was appointed chief resident during his third and fourth year in training. He is a member of multiple societies and a reviewer of numerous medical journals. His clinical, academic and research experience makes this candidate extremely well rounded to handle any neurology case. He currently works as an attending physician and researcher at a highly ranked university affiliated medical center.

This biomedical engineer specializes in materials science and biomechanics. He earned his B.S. and Ph.D. from New Jersey Institute of Technology, where he also served as a Postdoctoral Research Scientist overseeing the development and execution of experiments measuring neuronal activity after traumatic brain injuries. The expert is now an Adjunct Professor in Biomedical Engineering departments at two New Jersey higher education institutions.

This expert has been practicing toxicology for over 40 years. She holds a Master of Science in Clinical Chemistry as well as a Ph.D. in Toxicology, and an honorary doctoral degree in Medicine and Surgery from the Faculty of Medicine, University of Helsinki. She serves on the World Anti-Doping Agency's Prohibited List Committee, the National Commission on Forensic Sciences, the Organization of Scientific Area Committee on Toxicology, Transportation Research Board Committee on Alcohol and Other Drugs, and the National Safety Council's Alcohol, Drugs and Impairment Division Executive Board. She was a President of the International Association of Forensic Toxicologists, she is also a former President of the Society of Forensic Toxicologist and past Chair of the Toxicology Section of the American Academy of Forensic Sciences. She has published over 445 peer-reviewed articles and has presented more than 500 abstracts at national and international meetings, and she sits on the Editorial Board of multiple toxicological and chemical journals. She recently retired as Chief of Chemistry and Drug Metabolism, National Institute on Drug Abuse, National Institutes of Health. She serves as an Adjunct Professor at a major medical university. She consults with the US Department of Transportation, NMS Labs, and other diagnostic companies around the world. The journal Clinical Chemistry identified her as an inspiring mind.

This expert received her doctorate from the University of Michigan and worked as an environmental toxicologist for Syracuse Research Corporation, where she did quantitative human health risk assessment for the EPA on a variety of substances including solvents, pesticides and metals. As a certified industrial hygienist, certified professional ergonomist and environmental scientist she continues to apply her knowledge to improve occupational and environmental health.

This clinical development and regulatory expert has an M.S and Ph.D. in Pharmacology & Toxicology from West Virginia University. A member of the American Society of Clinical Pharmacology & Therapeutics, he has extensive product development experience in the pharmaceutical field. The expert spent his early career in clinical research roles, including a position as the Director of Clinical Research Operations for Univax Biologics. He has since founded/run a biotech development business and acts as both a Professor and Consultant in his field.

This expert has over 15 years experience in academia as it relates to Pharmacology. He has been accredited with the discovery of the RGS protein family, leading to 4 issued patents and numerous publications. In 2004 he was awarded the John Abel Award as an Outstanding American Pharmacologist under 40, from the American Society for Pharmacology & Experimental Therapeutics (ASPET). He is currently not only a Professor of Pharmacology, but also the Chair of the department and Director of the MD/PhD Scholars program at a University in West Virginia.

This highly-qualified environmental engineer is a recognized expert in air quality analysis, human health exposure, and risk assessment. He earned a BS in biochemistry from The College of Saint Rose followed by an MS in chemistry and a PhD in environmental science and engineering from Clarkson University. He is an elected member of several national committees, including serving as treasurer of the International Society for Exposure Science, on the board of directors for the Air & Waste Management Association, and as an expert panelist for the US EPA Air Quality Monitoring in Communities committee. He has formerly served as a staff scientist and principal investigator at the Health Effects Institute (HEI) and as a senior environmental toxicologist and environmental compliance manager for the Massachusetts Department of Public Health. He is currently the founder, chairman, and CEO for an air quality and human health exposure consultancy.

This highly qualified expert has 40 years of experience in the field of toxicology. He received his BS in biophysics before earning his PhD in toxicology and experimental pathology from Albany Medical College. He has extensive experience in mammalian toxicology, chemical risk assessment, product safety & stewardship, solvent toxicology, PCB toxicology, asbestos toxicology, and industrial chemicals toxicity. He is board certified in toxicology and is a retired member of the Society of Toxicology. He has formerly held a number of roles during his time with Sterling Research Group, including toxicologist of safety studies, group and research leader of comparative toxicology, and assistant research director of toxicology. He then served as a senior toxicologist for General Electric Global Research Center, senior managing scientist for Exponent Engineering and Scientific Consulting, and adjunct associate professor of environmental science at the State University of New York at Albany. Currently, this expert serves as an independent consultant of general toxicology for a private consulting firm in New York.

This highly qualified expert has extensive experience in emergency medicine. He obtained his BS in biology from Lafayette College, before receiving his MD from the Albany Medical College. He then completed a prestigious residency in emergency medicine at Brown University, where he was named chief resident, and a fellowship in medical toxicology at Denver Health/Rocky Mountain Poison & Drug Center. Today, this expert is board-certified in emergency medicine. He is an active member of the American College of Surgeons. He is also active in academia, having published 14 peer-reviewed journal articles and 4 book chapters on topics related to emergency medicine and clinical toxicology. This expert previously served as an assistant clinical instructor of emergency medicine at Brown University, as a clinical instructor of emergency medicine at the University of Colorado, and as an attending emergency medicine physician at the Medical Center of the Rockies and at the University of Colorado Hospital. He is currently an attending emergency medicine physician at a top hospital and an assistant professor of emergency medicine at a top medical school in New York.

This highly-qualified expert has nearly 45 years of experience in pharmacology. He specializes in pediatric clinical pharmacology, toxicology, and clinical pharmacy, as well as adverse drug reactions, drug-drug-food interactions, pharmacokinetics-pharmacodynamics, and pharmacogenomics. He earned both his BS in pharmacy and his PharmD from the University of Cincinnati. He also completed an internship in community pharmacy at Winston Place Pharmacy, an internship in hospital pharmacy at Holmes Hospital, and a residency in pediatric clinical pharmacy and clinical pharmacology at Children's Hospital Medical Center. This expert is board certified in applied pharmacology by the American Board of Clinical Pharmacology. He is active in his field as a member of the American Society of Hospital Pharmacists and the American College of Clinical Pharmacology. He has formerly served as the co-director of pediatric clinical pharmacology and toxicology at Rainbow Babies and Children's Hospital and the director of the clinical research center at Akron Children's Hospital. Additionally, he has held a variety of teaching positions, including as a tenured professor of pediatrics in the division of pediatric pharmacology and critical care at Case Western Reserve University and as a professor of pediatrics at Northeast Ohio Medical University. Currently, this expert is a professor emeritus of pediatrics at an Ohio university.

This highly-qualified expert has over 30 years of experience in pharmacology. He earned his BS in pharmacy from Albany College of Pharmacy before earning his PhD from Shenandoah University. He is a board-certified pharmacotherapy specialist and a licensed pharmacist. He also holds a certification in pediatric advanced life support. He is active in his field as an author of several scientific articles and as a member of several organizations, including the American Society of Health-System Pharmacists and the Pediatric Pharmacy Advocacy Group. He has formerly served as a pharmacist for Brooks Pharmacy, the Medical University of South Carolina, Mary Imogene Bassett Hospital, and Griffin Hospital. He also served as the director of pharmacy for Option Care (Infucor), a clinical pharmacy specialist at Yale-New Haven Hospital, and the director of pharmacy at Upstate University Hospital. Currently, this expert is the executive director of pharmacy services at a university-affiliated hospital in New York.